Orange Book product · Generic (ANDA)
NEOMYCIN SULFATE
NEOMYCIN SULFATE
At a glance
Jul 28, 2006
Approved
Generic (ANDA)
Application
AA
TE code
None
Listed patents
Key dates
Approval
FDA approval date of this drug product.
Jul 28, 2006
20 yr 2 mo ago
Today
Pharmaceutical detail
Active ingredient
NEOMYCIN SULFATE
Strength
500MG
Dosage form
TABLET
Route
ORAL
TE code
AA
Application
ANDA 065220
Product number
001
Marketing status
RX
Reference listed drug (RLD)
No
Reference standard (RS)
No
Active-ingredient family
View full familyGeneric (ANDA) of NEOMYCIN SULFATE
- —MYCIFRADINBrand (NDA)
NDA 050285 · PHARMACIA AND UPJOHN
- 2016NEOMYCIN SULFATEGeneric (ANDA)
ANDA 204435 · CHARTWELL MOLECULAR
- 2010NEOMYCIN SULFATEGeneric (ANDA)
ANDA 065468 · PHARMOBEDIENT
- 2002NEO-FRADINGeneric (ANDA)
ANDA 065010 · X GEN PHARMS
- —MYCIFRADINGeneric (ANDA)
ANDA 060520 · PHARMACIA AND UPJOHN
- —NEOBIOTICGeneric (ANDA)
ANDA 060475 · PFIZER
- —NEOMYCIN SULFATEGeneric (ANDA)
ANDA 060365 · BRISTOL MYERS SQUIBB
- —NEOMYCIN SULFATEGeneric (ANDA)
ANDA 060607 · LANNETT
- —NEOMYCIN SULFATEGeneric (ANDA)
ANDA 060385 · LILLY
- —NEOMYCIN SULFATEGeneric (ANDA)
ANDA 062173 · ROXANE
- —NEOMYCIN SULFATEGeneric (ANDA)
ANDA 061586 · SANDOZ
- —NEOMYCIN SULFATEGeneric (ANDA)
ANDA 060304 · TEVA
Listed patents
No patents are listed against this product in the Orange Book. Listed patents reflect those the NDA holder submits under 21 U.S.C. 355 and are not exhaustive.
